Global Wearable Injectors Market Share Is Expected To Grow At A CAGR Of 16.90% By 2028

19-Sep-2022 | Facts and Factors

According to Facts and Factors, the global wearable injectors market size was worth USD 5,284.10 million in 2021 and is estimated to grow to about USD 13485.22 million by 2028, with a compound annual growth rate (CAGR) of approximately 16.90% over the forecast period. The report analyzes the wearable injectors market drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the wearable injectors market.

Wearable injectors, called patch pumps, are condensed drug delivery systems designed for longer-term, one-step medication administration. They are drug delivery devices that attach to the body and automatically dispense patients' prescribed doses at the appropriate time. The drug is subcutaneously given over a pre-programmed period of seconds or hours using wearable injectors, single-use devices conveniently worn on the body. They administer huge quantities of sticky drugs via the body's subcutaneous tissues more swiftly and securely. The entire dose is injected, and then they are removed from the body and properly disposed of. Such devices have been made possible by the notion of patient centricity and a greater focus on human considerations in drug delivery design.

Browse the full “Wearable Injectors Market Size, Share, Growth Analysis Report By Type (On-Body Injector, Off-Body Injector), By Technology (Spring Based, Motor Based, Rotary Pump, Expanding Battery, Other Technology), By Therapy (Immuno-Oncology, Diabetes, Cardiovascular Disease, Other Disease), By End User (Hospitals and Clinics, Home Healthcare Setting), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" report at https://www.fnfresearch.com/wearable-injectors-market

The major factors driving the global wearable injector market growth are an increase in the prevalence of chronic diseases like diabetes, cardiovascular disease, cancer, and more; an increase in the use of biologics like monoclonal antibodies for treating diseases; and an increase in R&D activities for wearable injector devices like Bluetooth connectivity with smartphones and digital displays. A rise in the demand for home-based treatments and an increase in the number of senior patients both contribute to the market's expansion. Well-established healthcare infrastructure and the rise in the frequency of disorders linked to a sedentary lifestyle are additional factors driving market expansion. However, it is anticipated that low demand in developing countries and the expensive cost of wearable injectors will impede market expansion. Additionally, a rise in public-private funding for targeted research initiatives, an increase in demand for minimally invasive surgeries, an increase in children's participation in sports, and an increase in product novelties & development due to global technological advancements will prolong profitable periods for market players during the forecast period. The market will grow faster due to expanding internet penetration, rising arthroscopic surgery use, rising aged & obese populations worldwide, and rising per capita health care spending.

The global wearable injector market is segmented on type, technology, therapy, end user, and region. Based on type, the market is divided into the on-body injector and off-body injectors. The on-body segment dominated the market in 2021. Based on technology, the market is categorized as motor driven, spring driven, expanding battery, rotary pump, and other technology. The spring-driven segment dominated the market in 2021. Based on therapy, the market is divided into diabetes, immuno-oncology, cardiovascular disease, and other diseases. The diabetes segment dominated the market in 2021. Based on end-user, the market is divided into hospitals, clinics, and home care settings. The home care settings segment dominated the market in 2021.

In 2021, North America dominated the global wearable injectors market due to chronic illnesses and disorders linked to lifestyle becoming more common. Additionally, rising medical costs and investments in the construction of healthcare infrastructure are anticipated to fuel the global wearable injectors market expansion. Around 37 million Americans have diabetes, and 90 to 95% of them have type 2, according to the CDC. Additionally, the market is anticipated to grow due to the local presence of key market participants in the U.S., including Becton, Johnson & Johnson Services, Inc., Unilife Corporation, Dickinson and Company, Steady Med Therapeutics, Inc., Amgen, Inc., and Enable Injections. Developing various innovative drugs that can effectively treat chronic illnesses fuels the desire for wearable injectors. Additionally, the industry may benefit due to the increased popularity of customized medications.

Report Scope

Key players in the global wearable injectors market include Ypsomed, Amgen, Subcuject, Enable Injections, Medtronic Plc, Insulet Corporation, United Therapeutics Corp., CeQur SA, Sensile Medical, ATS Automation, West Pharmaceutical Services, Inc., Tandem Diabetes Care, Valeritas, Sonceboz, Noble, Elcam Drug Delivery Device, Bespak, Stevanato Group, Sorrel Medical, Weibel CDS AG and Neuma.

Recent Development:

• June 2020: With its Omnipod Insulin Management System, Insulet Corporation, a market leader in tubeless insulin pump technology, extended its financial assistance program for its American clients who were adversely affected by the COVID-19 pandemic. The customer may receive a free six-month supply of items (60 Pods) under the program.
• June 2019: A partnership between Enable Injections and Sanofi for the enFuse drug delivery platform was announced. With either standard nozzles or vial vessel forms, enFuse is a self-contained drug delivery stage.

Global Wearable Injectors Market is segmented as follows:

By Type

• On-body Injector
• Off-body Injector

By Technology

• Spring Based
• Motor Based
• Rotary pump
• Expanding battery
• Other technology

By Therapy

• Immuno-oncology
• Diabetes
• Cardiovascular disease
• Other diseases

By End User

• Hospitals and clinics
• Home healthcare settings

By Regional Segment Analysis

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com